Diabetic Ketoacidosis in Coronavirus Disease Patients With Type 2 Diabetes Mellitus.
| Autor: | Winn SP; Internal Medicine, University of Medicine 1, Yangon, MMR.; Internal Medicine, LaSante Health Center, Brooklyn, USA., Oo ZT; Internal Medicine, LaSante Health Center, Brooklyn, USA., Htun NN; Pathology, University of Medicine 1, Yangon, MMR., Soe MHP; Internal Medicine, University of Medicine 1, Yangon, MMR., Aung MM; Internal Medicine, University of Medicine 1, Yangon, MMR. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2020 Aug 14; Vol. 12 (8), pp. e9731. Date of Electronic Publication: 2020 Aug 14. |
| DOI: | 10.7759/cureus.9731 |
| Abstrakt: | The occurrence of diabetes is increasing globally and carries a variety of complications, such as thromboembolism, acute cerebrovascular accidents, and diabetic ketoacidosis (DKA). Although DKA is not commonly associated with type 2 diabetes (T2D), it can manifest in patients who have underlying comorbidities predisposed to DKA. Since the emergence of the coronavirus disease (COVID-19) pandemic, we have seen many cases and studies on the underlying pathophysiology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia with or without respiratory failure. We have also learned that the angiotensin-converting enzyme receptor is one of the major entry sites of SARS-CoV-2 infection, and it might be one of the causes that predispose patients to DKA. However, few studies exist that explore the development of DKA in T2D with SARS-CoV-2 infection. We present two cases of patients with DKA and COVID-19 treated with an insulin regimen with no further complications. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2020, Winn et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|